Dr. Flavia Pichiorri is a Los Angeles–based cancer researcher and scientific writer whose work focuses on translational and clinical strategies for hematologic malignancies. She is recognized for her contributions to therapies targeting CD38 and CD84, as well as radiation-based treatment approaches aimed at improving outcomes for patients with leukemia and multiple myeloma. With a background in molecular biology and biochemistry, Dr. Pichiorri has spent her career bridging laboratory discovery with early-phase clinical trials. Her research has contributed to the development of antibody-based therapies, immunotherapy strategies, and biomarker-driven approaches designed to translate scientific insight into real-world patient impact. Her work has been supported by multiple NIH grants and collaborative clinical research initiatives, reflecting a sustained commitment to advancing cancer treatment through rigorous, patient-focused science.